Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1996

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Risk of acute myocardial infarction and low-dose combined oral

contraceptives [letter]

AUTHORS

Jick H; Jick SS; Myers MW; Vasilakis C

SOURCE

Lancet. 1996 Mar 2;347(9001):627-8.

ABSTRACT

Researchers from Boston University Medical Center assessed 303,470 women who had used combined low estrogen

oral contraceptives (OCs) containing levonorgestrel, desogestrel, or gestodene between January 1991 and October

1994 to investigate the risk of myocardial infarction. 11 women had experienced an acute myocardial infarction or

sudden death. Each myocardial infarction case was matched to four controls by age, index date of the case, and

general practice. The relative risk for desogestrel, gestodene, and past use compared with levonorgestrel stood at

0.7, 0.6, and 0.9, respectively (95% confidence interval: 0.1-8.2, 0.1-6.4, and 0.2-4.5, respectively). 6 of the 11 cases

were either current smokers or past smokers. Based on these findings, the researchers concluded that users of low-

dose OCs were at low risk of myocardial infarction and any risk was limited to smokers. Further, these findings

support the findings of earlier studies that also found the risk of acute myocardial infarction to be very low in

otherwise healthy users of low-dose OCs. (PubHealth.info Document ID: CONT2T 2075-06)

PubHealth.info NOTE: The author(s) of this article titled, "Risk of acute myocardial infarction and low-dose combined

oral contraceptives [letter]", is(are) Jick H; Jick SS; Myers MW; Vasilakis C. The source of this article is "Lancet.

1996 Mar 2;347(9001):627-8.". This article was published in 1996 in English language(s). (PubHealth.info®

Document ID: CONT2T 2075-06. All rights reserved with PubHealth.info) PIN: 7075

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.